Laurus Labs Limited shareholders appointed Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee as Independent Directors for a term of five years effective July 2, 2026. The 21st Annual General Meeting (AGM), held via video conferencing, also ratified the adoption of audited financial statements for the financial year ended March 31, 2026, and approved two interim dividends totaling ₹2 per share for FY26.

The meeting ratified the first interim dividend of ₹0.80 per share and the second interim dividend of ₹1.20 per share, both paid for the financial year 2025-26. Shareholders approved the payment of remuneration to Non-Executive Directors, including Independent Directors, and the remuneration payable to Cost Auditors for the financial year ending 2026-27. Mr. Krishna Chaitanya Chava and Mrs. Soumya Chava were re-appointed as Directors, having retired by rotation.

Dr. Shekhar Chintamani Mande (DIN: 10083454) and Ms. Sutapa Banerjee (DIN: 02844650) are not related to any of the Directors or Key Managerial Personnel of the company. Based on their declarations, they are not debarred from holding the office of Director by virtue of any SEBI order or any other such authority. The appointment of Ms. Banerjee received 91.65% votes in favour.

The remote e-voting facility, provided by National Securities Depository Limited (NSDL), was open from June 29, 2026, to July 1, 2026. A total of 1,189 members participated in the e-voting process. The meeting commenced at 3:00 p.m. IST and concluded at 3:57 p.m. IST. Mr. Y. Ravi Prasada Reddy, Proprietor of M/s RPR & Associates, served as the Scrutinizer for the voting process.

Laurus Labs recorded a significant block trade on the National Stock Exchange (NSE), with approximately 1,98,476 shares changing hands at a price of ₹1490.50 per share. The total value of the transaction amounted to ₹29.58 crores, reflecting substantial institutional-level activity in the stock.

Block Trade Details

The following table summarizes the key parameters of the block trade executed on the NSE:

Block trades are large-volume transactions typically executed by institutional investors or major market participants, often carried out outside the regular order book to minimize market impact. The execution of such a trade in Laurus Labs underscores the continued interest of large-scale investors in the company's shares.